Evidence map›Paper›PMID 31434739›Full record

ArticleThe Journal of biological chemistry2019

Sex-specific hepatic lipid and bile acid metabolism alterations in

Elizabeth S Moore, Erin K Daugherity, David I Karambizi, Bethany P Cummings, Erica Behling-Kelly, Deanna M W Schaefer, Teresa L Southard, Joseph W McFadden, Robert S Weiss

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elizabeth S MooreDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853.ORCID 0000-0003-2502-6429
Erin K DaugherityDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853.
David I KarambiziDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853.
Bethany P CummingsDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853.
Erica Behling-KellyDepartment of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, New York 14853.
Deanna M W SchaeferDepartment of Biomedical and Diagnostic Sciences, University of Tennessee, Knoxville, Tennessee 37996.ORCID 0000-0002-5260-2180
Teresa L SouthardDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853.ORCID 0000-0001-8388-7951
Joseph W McFaddenDepartment of Animal Science, Cornell University, Ithaca, New York 14853.
Robert S WeissDepartment of Biomedical Sciences, Cornell University, Ithaca, New York 14853 rsw26@cornell.edu.ORCID 0000-0003-3327-1379
Cornell University · USUniversity of Tennessee at Knoxville · US

Funding

Graduate Training Program in Comparative MedicineT32OD011000 · CORNELL UNIVERSITY · 2025 to 2025
$0k
NIH HHS T32 OD011000
6 · The paper itself

Abstract

Defects in the Fanconi anemia (FA) DNA damage-response pathway result in genomic instability, developmental defects, hematopoietic failure, cancer predisposition, and metabolic disorders. The endogenous sources of damage contributing to FA phenotypes and the links between FA and metabolic disease remain poorly understood. Here, using mice lacking the

Indexed as

DietLipid MetabolismSex CharacteristicsAnimalsBileCholesterolDigestive System DiseasesDisease SusceptibilityDNA DamageFanconi Anemia Complementation Group D2 ProteinFeeding BehaviorFemaleGene Expression RegulationKineticsLiverMaleCholesterolFanconi Anemia Complementation Group D2 Proteincholestasischolesterol metabolismDNA damage responseFanconi anemiaFanconi anemia complementation group D2 (FANCD2)fatty acid metabolismlipid metabolismliver metabolismmetabolic syndromenonalcoholic fatty liver disease

Identifiers

PMID31434739
PMCPMC6816084
OpenAlexW2969226491

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.